HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice.

AbstractOBJECTIVE:
To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-).
METHODS AND RESULTS:
Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8%+/-0.4% versus 6.4%+/-0.8%, mean+/-SEM, P<0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P<0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P<0.01) and had a lower body fat content (3.5%+/-1.0% versus 13.1%+/-3.0%, P<0.01). There were no differences between FB-/- mice and controls.
CONCLUSIONS:
Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
AuthorsLinda Persson, Jan Borén, Anna-Karin L Robertson, Ville Wallenius, Göran K Hansson, Marcela Pekna
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 24 Issue 6 Pg. 1062-7 (Jun 2004) ISSN: 1524-4636 [Electronic] United States
PMID15059809 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • Cholesterol, LDL
  • Complement C3
  • Lipoproteins, VLDL
  • Receptors, LDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Complement Factor B
Topics
  • Animals
  • Aortic Diseases (blood, genetics, pathology)
  • Apolipoproteins E (deficiency, genetics)
  • Arteriosclerosis (blood, genetics, pathology)
  • Cholesterol, LDL (blood)
  • Complement C3 (deficiency, genetics, physiology)
  • Complement Factor B (deficiency, genetics, physiology)
  • Complement Pathway, Alternative (genetics)
  • Complement Pathway, Classical (genetics)
  • Crosses, Genetic
  • Female
  • Genetic Predisposition to Disease
  • Hyperlipoproteinemia Type II (blood, genetics)
  • Hyperlipoproteinemia Type IV (blood, genetics)
  • Lipoproteins, VLDL (blood)
  • Male
  • Mice
  • Mice, Knockout
  • Receptors, LDL (deficiency, genetics)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: